(Q40875262)

English

Advantage of yttrium-90-labeled over iodine-131-labeled monoclonal antibodies in the treatment of a human lung carcinoma xenograft

scientific article

Statements

Advantage of yttrium-90-labeled over iodine-131-labeled monoclonal antibodies in the treatment of a human lung carcinoma xenograft (English)
1 December 1997
12 Suppl
2636-2641

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit